Ed Gemo
Director Técnico/Científico/I+D en TURG POIN .
Origen de la red de primer grado Ed Gemo.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ed Gemo a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Compliance Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | President | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vesselon, Inc.
 Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Medical Specialties | Director/Board Member | |
| DERMATA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Stanford University | College/University | Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree | |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member President | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| The University of Southampton | College/University | Doctorate Degree | |
| University of California, Irvine | College/University | Masters Business Admin | |
| University of Illinois | College/University | Doctorate Degree | |
| University of Phoenix | College/University | Masters Business Admin | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
| University of Delhi | College/University | Doctorate Degree | |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
| BIONANO GENOMICS, INC. | Biotechnology | Corporate Secretary | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal | |
AbbVie Bioresearch Center, Inc.
 AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Bioresearch Center, Inc. is a company that provides drug discovery, development sciences, and biologics research services. The company is based in Worcester, MA. | Biotechnology | Corporate Officer/Principal | |
| Columbia University Medical Center | College/University | Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | General Counsel | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member President | |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Director of Finance/CFO | |
| University of California | College/University | Graduate Degree | |
Takeda California, Inc.
 Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Takeda California, Inc. is a pharmaceutical manufacturing company. The private company is based in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The City College of New York | College/University | Undergraduate Degree | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Director/Board Member | |
| Temple University School of Medicine | College/University | Doctorate Degree | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chief Operating Officer | |
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Investor Relations Contact | |
| Eurofins Discovery Products France SAS | Corporate Officer/Principal | ||
TEGA Therapeutics, Inc.
 TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Biotechnology | Director of Finance/CFO | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Human Connexus Foundation | Founder | ||
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 45 |
| Canadá | 3 |
| Reino Unido | 2 |
| India | 2 |
| Suiza | 2 |
Sectorial
| Health Technology | 31 |
| Consumer Services | 14 |
| Health Services | 4 |
| Commercial Services | 2 |
Operativa
| Corporate Officer/Principal | 18 |
| Director/Board Member | 13 |
| Corporate Secretary | 8 |
| Undergraduate Degree | 6 |
| Doctorate Degree | 4 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Ed Gemo
- Conexiones Empresas
